Mostrar el registro sencillo del ítem

dc.contributor.authorRodríguez Cabello, José Carlos 
dc.contributor.authorMartín Maroto, Laura 
dc.contributor.authorGirotti, Alessandra
dc.contributor.authorGarcía-Arévalo, Carmen
dc.contributor.authorArias, F Javier
dc.contributor.authorAlonso, Matilde
dc.date.accessioned2026-02-17T10:03:23Z
dc.date.available2026-02-17T10:03:23Z
dc.date.issued2010
dc.identifier.citationNanomedicine, 2010, 6(1), 111–122es
dc.identifier.issn1743-5889es
dc.identifier.urihttps://uvadoc.uva.es/handle/10324/82813
dc.description.abstractElastin-like recombinamers have grown in popularity in the field of protein-inspired biomimetic materials and have found widespread use in biomedical applications. Modern genetic-engineering techniques have allowed the design of multifunctional materials with an extraordinary control over their architecture and physicochemical properties, such as stimuli-responsiveness, monodispersity, biocompatibility or self-assembly, amongst others. Indeed, these materials are playing an increasingly important role in a diverse range of applications, such as drug delivery, tissue engineering and ‘smart’ systems. Herein, we review some of the most interesting examples of recent advances and progressive applications of elastin-like recombinamers in biomaterial and nano-engineering sciences in recent years.es
dc.format.mimetypeapplication/pdfes
dc.language.isoenges
dc.publisherTaylor & Francises
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.titleEmerging Applications of Multifunctional Elastin-Like Recombinamerses
dc.typeinfo:eu-repo/semantics/articlees
dc.identifier.doi10.2217/nnm.10.141es
dc.relation.publisherversionhttps://www.tandfonline.com/doi/full/10.2217/nnm.10.141es
dc.identifier.publicationfirstpage111es
dc.identifier.publicationissue1es
dc.identifier.publicationlastpage122es
dc.identifier.publicationtitleNanomedicinees
dc.identifier.publicationvolume6es
dc.peerreviewedSIes
dc.description.projectThe authors acknowledge financial support through the European Regional Development Fund from the EU, from the Ministerio de Ciencia e Innovación – Inoicio (MICINN; projects MAT 2007-66275-C02-01, MAT 2007-61604, MAT 2009-14195-C03-03 and PSE-300100-2006-2001), the Junta de Castilla y León (JCyL; projects VA034A09 and VA030A08), the El Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (project CB06-01-0003), the JCyL and the Instituto de Salud Carlos III under the ‘Network Center of Regenerative Medicine and Cellular Therapy of Castilla and León‘. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.es
dc.identifier.essn1748-6963es
dc.type.hasVersioninfo:eu-repo/semantics/submittedVersiones


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem